July 2022

NDARC researchers have been awarded $1.7 million over four years for a program of work focused on the prevention of AOD use and harms in rural and regional NSW.

July 2022

NDARC’s Ryan Courtney has been awarded $2.7 million to compare the cost-effectiveness of vaporised nicotine products (VNPs) and varenicline.

July 2022

NDRI Melbourne’s Samantha College-Frisby presented NDRI’s July webinar, sharing findings from studies examining the impact of opioid agonist treatment (OAT) on ho

July 2022

NCCRED is producing a series of VANs showcasing NCCRED supported research, developed for both consumers and healthcare professionals.

July 2022

It has been a busy two months for NDRI researchers in the media, with expert commentary provided on a wide variety of AOD topics.

May 2022

NDARC’s Olivia Price discusses vaccine hesitancy amongst people who inject drugs.

May 2022

The National Centre for Clinical Research on Emerging Drugs has published a new AOD Telephone Counselling toolkit containing eLearning modules, videos, tip sheets and other resources.

May 2022

The Your WorkLife website and resources continue to be popular with over 8,000 hits on the Toolbox topics, nearly 12,000 hits on the suite of factsheets available for download, and just over 3,000 hits on the how-to-guides.

May 2022

NDRI’s webinar program continues during National Reconciliation Week 2022 with a presentation from PhD Scholar Anna Stearne.

May 2022

Naloxone will be available in all Australian states and territories at no cost and without a prescription from July 1.

Pages